➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Merck
Harvard Business School
Colorcon
AstraZeneca

Last Updated: August 3, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GANIRELIX ACETATE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for GANIRELIX ACETATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00298025 ↗ A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation Completed EMD Serono Phase 4 2003-09-01 To demonstrate the comparative safety and efficacy of Cetrotide® 3 milligram (mg) and Antagon™ in the inhibition of a premature luteinizing hormone (LH) surge in women undergoing ovarian stimulation with recombinant human follicle stimulating hormone/human menopausal gonadotropin (r-hFSH/hMG) prior to assisted reproductive technology (ART) and utilizing oral contraceptives pill (OCP) for cycle programming.
NCT00734279 ↗ Follicle-Stimulating Hormone (FSH) and the Onset of Puberty Completed University of Chicago N/A 2006-03-01 The purpose of this study is to determine if the timing of the onset of puberty may be affected by FSH-regulatory peptides. We will determine how these peptides relate to FSH production in prepubertal and pubertal children by comparing the regulation of FSH control in children with precocious (early) puberty and delayed puberty. In this pilot study, we will stimulate the pubertal axis using an agonist of GnRH to determine the pubertal response of activin-A, inhibin-A and -B and follistatin. To determine baseline FSH secretion and FSH-regulatory peptide tone, we will block GnRH with a specific antagonist. These studies should lead to a better understanding of the role of FSH in controlling the onset of puberty and the pathogenesis of pubertal disorders.
NCT00734279 ↗ Follicle-Stimulating Hormone (FSH) and the Onset of Puberty Completed University of Michigan N/A 2006-03-01 The purpose of this study is to determine if the timing of the onset of puberty may be affected by FSH-regulatory peptides. We will determine how these peptides relate to FSH production in prepubertal and pubertal children by comparing the regulation of FSH control in children with precocious (early) puberty and delayed puberty. In this pilot study, we will stimulate the pubertal axis using an agonist of GnRH to determine the pubertal response of activin-A, inhibin-A and -B and follistatin. To determine baseline FSH secretion and FSH-regulatory peptide tone, we will block GnRH with a specific antagonist. These studies should lead to a better understanding of the role of FSH in controlling the onset of puberty and the pathogenesis of pubertal disorders.
NCT00734279 ↗ Follicle-Stimulating Hormone (FSH) and the Onset of Puberty Completed University of Utah N/A 2006-03-01 The purpose of this study is to determine if the timing of the onset of puberty may be affected by FSH-regulatory peptides. We will determine how these peptides relate to FSH production in prepubertal and pubertal children by comparing the regulation of FSH control in children with precocious (early) puberty and delayed puberty. In this pilot study, we will stimulate the pubertal axis using an agonist of GnRH to determine the pubertal response of activin-A, inhibin-A and -B and follistatin. To determine baseline FSH secretion and FSH-regulatory peptide tone, we will block GnRH with a specific antagonist. These studies should lead to a better understanding of the role of FSH in controlling the onset of puberty and the pathogenesis of pubertal disorders.
NCT00802360 ↗ MENOPUR® Versus FOLLISTIM® Completed Ferring Pharmaceuticals Phase 4 2008-12-01 To compare the efficacy and safety of highly purified menotropin (Menopur®) with that of follitropin beta (FOLLISTIM®) in patients who are undergoing gonadotropin-releasing hormone (GnRH) antagonist in vitro fertilization (IVF) cycles
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for GANIRELIX ACETATE

Condition Name

Condition Name for GANIRELIX ACETATE
Intervention Trials
Infertility 6
Controlled Ovarian Stimulation 2
Fertility 2
Diminished Ovarian Reserve 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for GANIRELIX ACETATE
Intervention Trials
Infertility 7
Ovarian Hyperstimulation Syndrome 1
Puberty, Precocious 1
Cerebral Arterial Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for GANIRELIX ACETATE

Trials by Country

Trials by Country for GANIRELIX ACETATE
Location Trials
United States 13
Italy 2
Poland 1
Turkey 1
Iran, Islamic Republic of 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for GANIRELIX ACETATE
Location Trials
Pennsylvania 2
California 2
Wisconsin 1
Michigan 1
Virginia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for GANIRELIX ACETATE

Clinical Trial Phase

Clinical Trial Phase for GANIRELIX ACETATE
Clinical Trial Phase Trials
Phase 4 7
Phase 3 1
Phase 2 1
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for GANIRELIX ACETATE
Clinical Trial Phase Trials
Completed 9
Recruiting 5
Not yet recruiting 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for GANIRELIX ACETATE

Sponsor Name

Sponsor Name for GANIRELIX ACETATE
Sponsor Trials
Merck Sharp & Dohme Corp. 3
Ferring Pharmaceuticals 3
Main Line Fertility Center 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for GANIRELIX ACETATE
Sponsor Trials
Other 15
Industry 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
McKesson
Medtronic
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.